Tilray Guides FY27 Adjusted EBITDA to $68M-$75M, Signaling Profit Growth
TLRY is trading near its 52-week low of $3.8 (7.8% above the low).
Summary
Tilray Brands issued FY27 Adjusted EBITDA guidance of $68 million to $75 million, a concrete profitability target that exceeds recent run rates. The company reported a substantial reduction in net loss and improved Adjusted EBITDA in its last 10-Q, driven by operational efficiencies and absence of prior impairments. This guidance suggests management expects continued margin expansion and cost discipline. The range implies meaningful growth from current levels, though the market will weigh it against the company's $484 million market cap and ongoing dilution from debt conversions. No specific catalyst date is set, but the guidance provides a benchmark for upcoming quarters.
At the time of this announcement, TLRY was trading at $4.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $483.6M. The 52-week trading range was $3.80 to $23.20. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.